Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine

被引:24
|
作者
Zugno, Alexandra I. [1 ]
Canever, Lara [1 ]
Heylmann, Alexandra S. [1 ]
Wessler, Patricia G. [1 ]
Steckert, Amanda [1 ]
Mastella, Gustavo A. [1 ]
de Oliveira, Mariana B. [1 ]
Damazio, Louyse S. [1 ]
Pacheco, Felipe D. [1 ]
Calixto, Octacilio P. [1 ]
Pereira, Flavio P. [1 ]
Macan, Tamires P. [3 ]
Pedro, Thayara H. [3 ]
Schuck, Patricia F. [3 ]
Quevedo, Joao [1 ,2 ]
Budni, Josiane [1 ]
机构
[1] Univ Extremo Sul Catarinense, Lab Neurociencias, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, BR-88806000 Criciuma, SC, Brazil
[2] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Sch Med, Ctr Expt Models Psychiat, Houston, TX 77030 USA
[3] Univ Extrema Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metab, Criciuma, SC, Brazil
关键词
Schizophrenia; Folic acid; Ketamine; Behavioral; Oxidative stress; LIPID-PEROXIDATION; FOLLOW-UP; FOLATE; HOMOCYSTEINE; SYMPTOMS; THERAPEUTICS; DEPRESSION; PREGNANCY; RISK; RATS;
D O I
10.1016/j.jpsychires.2016.06.013
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Recent studies have shown benefits for the supplementation of folic acid in schizophrenic patients. The aim of this study was to evaluate the effects of folic acid addition on adult rats, over a period of 7 or 14 days. It also sets out to verify any potential protective action using an animal model of schizophrenia induced by ketamine, in behavioral and biochemical parameters. This study used two protocols (acute and chronic) for the administration of ketamine at a dose of 25 mg/kg (i.p.). The folic acid was given by oral route in doses of 5, 10 and 50 mg/kg, once daily, for 7 and/or 14 days in order to compare the protective effects of folic acid. Thirty minutes after the last administration of ketamine, the locomotor and social interaction activities were evaluated, and immediately the brain structure were removed for biochemical analysis. In this study, ketamine was administered in a single dose or in doses over the course of 7 days increasing the animal's locomotion. This study showed that the administration of folic acid over 7 days was unable to prevent hyper locomotion. In contrast, folic acid (10 and 50 mg/kg) administrated over a period of 14 days, was able to partially prevent the hyper locomotion. Our data indicates that both acute and chronic administrations of ketamine increased the time to first contact between the animals, while the increased latency for social contact was completely prevented by folic acid (5, 10 and 50 mg/kg). Chronic and acute administrations of ketamine also increased lipid peroxidation and protein carbonylation in brain. Folic acid (10 and 50 mg/kg) supplements showed protective effects on the oxidative damage found in the different brain structures evaluated. All together, the results indicate that nutritional supplementation with folic acid provides promising results in an animal model of schizophrenia induced by ketamine. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:23 / 35
页数:13
相关论文
共 50 条
  • [1] Effect of sepsis on behavioral changes on the ketamine-induced animal model of schizophrenia
    Comim, Clarissa M.
    Silva, Napoleao C.
    Patricio, Janini J.
    Palmas, Daphne
    Mendonca, Bruna P.
    Bittencourt, Mariana O.
    Cassol, Omar J., Jr.
    Barichello, Tatiana
    Zugno, Alexandra I.
    Quevedo, Joao
    Dal-Pizzol, Felipe
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2015, 281 : 78 - 82
  • [2] Nicorandil reverses the behavioral changes and brain oxidative stress in a model of schizophrenia induced by ketamine in mice
    Abdel-Salam O.M.E.
    El-Shamarka M.E.-S.
    [J]. Comparative Clinical Pathology, 2017, 26 (4) : 955 - 963
  • [3] EFFECT OF MATERNAL DEPRIVATION ON ACETYLCHOLINESTERASE ACTIVITY AND BEHAVIORAL CHANGES ON THE KETAMINE-INDUCED ANIMAL MODEL OF SCHIZOPHRENIA
    Zugno, A. I.
    de Miranda, I. M.
    Budni, J.
    Volpato, A. M.
    Luca, R. D.
    Deroza, P. F.
    de Oliveira, M. B.
    Heylmann, A. S.
    da Rosa Silveira, F.
    Wessler, P.
    Antunes Mastella, G.
    Cipriano, A. L.
    Quevedo, J.
    [J]. NEUROSCIENCE, 2013, 248 : 252 - 260
  • [4] BEHAVIORAL CHANGES AND MITOCHONDRIAL DYSFUNCTION IN RATS SUBMITTED TO ANIMAL MODEL OF SCHIZOPHRENIA INDUCED BY KETAMINE
    Zugno, Alexandra Ioppi
    Oliveira, Larissa
    Luca, Renata
    Canever, Leila
    Ghedim, Fernando V.
    Fraga, Daiane de Bitttencourt
    Matos, Maria P.
    Streck, Emilio L.
    Quevedo, Joao
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 114 - 114
  • [5] Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences
    Leite Sampaio, Luis Rafael
    Mauricio Sales Cysne Filho, Francisco
    de Almeida, Jamily Cunha
    Diniz, Danilo dos Santos
    Vasconcelos Patrocinio, Claudio Felipe
    Soares de Sousa, Caren Nadia
    Azevedo Patrocinio, Manoel Claudio
    Macedo, Danielle
    Mendes Vasconcelos, Silvania Maria
    [J]. NEUROSCIENCE, 2018, 373 : 72 - 81
  • [6] Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine
    de Oliveira, Larissa
    Fraga, Daiane B.
    De Luca, Renata D.
    Canever, Leila
    Ghedim, Fernando V.
    Matos, Maria Paula P.
    Streck, Emilio L.
    Quevedo, Joao
    Zugno, Alexandra I.
    [J]. METABOLIC BRAIN DISEASE, 2011, 26 (01) : 69 - 77
  • [7] Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine
    Larissa de Oliveira
    Daiane B. Fraga
    Renata D. De Luca
    Leila Canever
    Fernando V. Ghedim
    Maria Paula P. Matos
    Emilio L. Streck
    João Quevedo
    Alexandra I. Zugno
    [J]. Metabolic Brain Disease, 2011, 26 : 69 - 77
  • [8] EFFECT OF OMEGA 3 SUPPLEMENTATION IN AN ANIMAL MODEL SCHIZOPHRENIA INDUCED BY KETAMINE
    Miranda, Isabelle M.
    Canever, Lara
    de Luca, Renata
    Deroza, Pedro F.
    Gama, Clarissa S.
    Zugno, Aexandra I.
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 136 : S325 - S325
  • [9] Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia
    Becker, A
    Peters, B
    Schroeder, H
    Mann, T
    Huether, G
    Grecksch, G
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (04): : 687 - 700
  • [10] Neuroprotective effect of hesperidin and its combination with coenzyme Q10 on an animal model of ketamine-induced psychosis: behavioral changes, mitochondrial dysfunctions, and oxidative stress
    Naresh Kumar
    Monu Yadav
    Anil Kumar
    Monika Kadian
    Sunil Kumar
    [J]. Future Journal of Pharmaceutical Sciences, 8